Short- and Long-term Behavioral, Cognitive and Motor Outcomes of Frameless Deep Brain Stimulation in Patients With Parkinson's Disease: a Prospective Observational Study
Recruiting
- Conditions
- Parkinson Disease
- Registration Number
- NCT05752656
- Brief Summary
The main objective of the study is to evaluate the improvement in quality of life after deep brain stimulation surgery with frameless technique by comparing the PDQ-39 scale score at baseline (before surgery) and one year after surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- diagnosis of idiopathic Parkinson's disease according to Movement Disorder Society (MDS) criteria;
- patients who are candidates for deep brain stimulation intervention, according to the international criteria of the "Core assessment program for surgical interventional therapies in Parkinson's disease" (CAPSIT-PD).
Exclusion Criteria
- patients unable to give informed consent.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of quality of life One year Evaluation of the PDQ-39 scale score at baseline (before surgery) and one year after surgery.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie frameless DBS effects on Parkinson's disease progression?
How does frameless deep brain stimulation compare to traditional DBS in motor symptom management for Parkinson's patients?
Are there specific biomarkers that predict cognitive outcomes following frameless DBS in Parkinson's disease?
What are the potential adverse events associated with frameless DBS in Parkinson's disease and how are they managed?
What combination therapies or competitor drugs are being explored alongside frameless DBS for Parkinson's treatment?
Trial Locations
- Locations (1)
Flavia Torlizzi
🇮🇹Rome, Italy
Flavia Torlizzi🇮🇹Rome, ItalyFlavia TorlizziContact+390630156433flavia.torlizzi@policlinicogemelli.it